Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-30 Option Award | 2023-07-05 9:49 pm | N/A 2033-06-29 | Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 8:52 pm | N/A 2033-06-15 | Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:06 pm | N/A 2032-06-15 | Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:43 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director | 86,467 | $0 | 86,467 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-15 5:53 pm | N/A N/A | ARYA Sciences Acquisition Corp V | ARYE | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner | 499,000 | $10 | 499,000 (Indirect) | View |
Ownership | 2021-07-12 8:07 pm | N/A N/A | ARYA Sciences Acquisition Corp V | ARYE | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner | 0 | $0 | 3,617,500 (Indirect) | View |
| 2021-06-09 Option Award | 2021-06-11 5:32 pm | 2021-06-09 2031-06-09 | Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director | 44,435 | $0 | 543,435 (Direct) | View |
| 2021-06-09 Conversion | 2021-06-11 5:32 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director | 4,146,500 | $0 | 543,435 (Indirect) | View |
| 2021-05-26 Option Award | 2021-05-28 6:28 pm | N/A 2031-05-25 | Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-02 4:30 pm | N/A N/A | ARYA Sciences Acquisition Corp IV | ARYD | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner | 499,000 | $10 | 499,000 (Indirect) | View |
Ownership | 2021-02-25 8:32 pm | N/A N/A | ARYA Sciences Acquisition Corp IV | ARYD | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner | 0 | $0 | 3,647,500 (Indirect) | View |
| 2020-08-11 Other | 2020-08-11 8:38 pm | N/A N/A | ARYA Sciences Acquisition Corp III | ARYA | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner | 499,000 | $10 | 998,000 (Indirect) | View |
Ownership | 2020-08-06 9:47 pm | N/A N/A | ARYA Sciences Acquisition Corp III | ARYA | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner | 0 | $0 | 3,647,500 (Indirect) | View |
| 2020-06-09 Other | 2020-06-09 8:23 pm | N/A N/A | ARYA Sciences Acquisition Corp II | ARYB | ALTMAN MICHAEL SETH Chief Financial Officer | 499,000 | $10 | 998,000 (Indirect) | View |
Ownership | 2020-06-04 9:46 pm | N/A N/A | ARYA Sciences Acquisition Corp II | ARYB | ALTMAN MICHAEL SETH Chief Financial Officer | 0 | $0 | 3,647,500 (Indirect) | View |
| 2020-04-30 Option Award | 2020-05-01 6:44 pm | N/A 2030-04-29 | Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director | 14,500 | $0 | 14,500 (Direct) | View |